期刊文献+

P-糖蛋白介导的药代动力学及其药物相互作用 被引量:26

Effects of P-glycoprotein on the pharmacokinetics and interaction mediated by P-glycoprotein
下载PDF
导出
摘要 P-糖蛋白是一个能量依赖性转运蛋白,能将许多结构不同的化合物逆向转运出细胞。它除了在肿瘤组织过度表达引起多药耐药外,在人体正常组织肝、肾、小肠、血脑屏障、肌肉组织、肾上腺等部位也有分布,对许多种药物的药代动力学具有调控作用。本文综述P-糖蛋白对药代动力学的作用及由P-糖蛋白的诱导和抑制所引起的药物相互作用。 P-glycoprotein is an ATP-driven efflux pump which transport a wide variety of structurally diverse compounds from the cell interior into the extracellular space. Apart from in tumor causing multidrug resistance, it is also localized in healthy tissues such as liver, kidney, intestinal, blood-brain barrier, muscles and adrenal gland etc, and can modulate the pharmacokinetics of a lot of compounds. The role of P-glycoprotein in absorption, distribution, metabolism, excretion and the drug-drug interaction mediated by induction and inhibition of P-glycoprotein are reviewed in this paper.
出处 《中国临床药理学杂志》 CAS CSCD 北大核心 2004年第2期139-143,共5页 The Chinese Journal of Clinical Pharmacology
关键词 P-糖蛋白 介导 药代动力学 药物相互作用 血脑屏障 P-glycoprotein pharmacokinetics drug-drug interaction
  • 相关文献

参考文献36

  • 1[1]Lown KS, Mayo RR, Leichtman AB, et al. Role of intestinal Pglycoprotein (mdrl) in interpatient variation in the oral bioavailability of cyclosporine[J]. Clin Pharmacol Ther, 1997;62:248-260.
  • 2[2]Maggio-Price L, Shows D, Waggie K, et al. Helicobacter bilis infection accelerates and H. hepaticus infection delays the development of colitis in multiple drug resistance-deficient (mdrla-/-)mice[J]. Am J Pathol, 2002; 160:739-751.
  • 3[3]Hunter J, Jepson MA, Tsuruo T, et al. Functional expression of Pglycoprotein in apical membranes of human intestinal Caco-2cells. Kinetics of vinblastine secretion and interaction with modulators[J]. J Biol Chem, 1993;268:14991-14997.
  • 4[4]Sparreboom A, van Asperen J, Mayer U, et al. Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol)caused by P-glycoprotein in the intestine[J]. Proc Natl Acad Sci USA, 1997;94:2031-2035.
  • 5[5]Malingre MM, Richel DJ, Beijnen JH, et al. Coadministration of cyclosporine strongly enhances the oral bioavailability of docetaxel[J]. J Clin Oncol, 2001;19:1160-1166.
  • 6[6]Masuda S, Uemoto S, Hashida T, et al. Effect of intestinal P-glycoprotein on daily tacrolimus trough level in a living-donor small bowel recipient[J]. Clin Pharmacol Ther, 2000;68:98-103.
  • 7[7]Masuda S, Goto M, Kiuchi T, et al. Enhanced expression of enterocyte P-glycoprotein depresses cyclosporine bioavailability in a recipient of living donor liver transplantation[J]. Liver Transpl, 2003;9:1108-1113.
  • 8[8]Wetterich U, Spahn-Langguth H, Mutschler E, et al. Evidence for intestinal secretion as an additional clearance pathway of talinolol enantiomers: concentration-and dose-dependent absorption in vitro and in vivo[J]. Pharrn Res, 1996;13:514-522.
  • 9[9]Ueda CT, Lemaire M, Gsell G, et al. Apparent dose-dependent oral absorption ofcyciosporin A in rats[J]. Biopharmn Drug Dispos,1984;5:141-151.
  • 10[10]Lee G, Schlichter L, Bendayan M, et al. Functional expression of P-glycoprotein in rat brain microglia[J]. J Pharmacol Exp Ther,2001 ;299:204-212.

同被引文献323

引证文献26

二级引证文献122

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部